Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Human liver cells stick to hair protein materials mainly through the liver's asialoglycoprotein receptor.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

ILK and ELMO2 help cells move and stick together, important for wound healing and hair growth.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Newborn mouse skin cells can grow hair and this process can be recreated in adult cells to potentially help with hair loss.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Plant roots respond to fungus smells by possibly using certain proteins and a plant hormone to change root growth, but more research is needed.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

EGF controls hair growth by regulating hair follicles' growth phases.

Targeting the Smoothened receptor shows promise for treating certain cancers.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

The TGF-β family helps control how cells change and move, affecting skin, hair, and organ development.

Normal human melanocytes can avoid cell death through multiple pathways.

Gab1 protein is crucial for hair growth and stem cell renewal, and Mapk signaling helps maintain these processes.

Skin reactions from cancer treatments might predict how well the treatments work.

Researchers found genes and microRNAs that control curly fleece in Chinese Tan sheep.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.